Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy.
Borthakur G, Kantarjian H, Daley G, Talpaz M, O'Brien S, Garcia-Manero G, Giles F, Faderl S, Sugrue M, Cortes J. Borthakur G, et al. Among authors: sugrue m. Cancer. 2006 Jan 15;106(2):346-52. doi: 10.1002/cncr.21590. Cancer. 2006. PMID: 16342165 Free article. Clinical Trial.
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H. Steensma DP, et al. Among authors: sugrue mm. BMC Cancer. 2016 Aug 19;16:652. doi: 10.1186/s12885-016-2710-6. BMC Cancer. 2016. PMID: 27538433 Free PMC article.
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.
Prebet T, Cluzeau T, Park S, Sekeres MA, Germing U, Ades L, Platzbecker U, Gotze K, Vey N, Oliva E, Sugrue MM, Bally C, Kelaidi C, Al Ali N, Fenaux P, Gore SD, Komrokji R. Prebet T, et al. Among authors: sugrue mm. Oncotarget. 2017 Jun 14;8(47):81926-81935. doi: 10.18632/oncotarget.18477. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137233 Free PMC article.
Current pathology practices in and barriers to MDS diagnosis.
Glauser TA, Sagatys EM, Williamson JC, Burton BS, Berger C, Merwin P, Sugrue M, Bennett JM. Glauser TA, et al. Among authors: sugrue m. Leuk Res. 2013 Dec;37(12):1656-61. doi: 10.1016/j.leukres.2013.10.007. Epub 2013 Oct 22. Leuk Res. 2013. PMID: 24220584
356 results